Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-04

Clinical Trial Update: Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pre-transplant treatment to prevent hepatitis C recurrence after liver transplantation has completed, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2013-04-04